INHIBITORS OF CELL CYCLE CHECKPOINT KINASE 1 FOR AMPLIFICATION OF DNA-DAMAGING AGENTS Russian patent published in 2015 - IPC A61K31/454 A61K31/4375 A61K31/4545 A61K45/00 A61P35/00 

Abstract RU 2567044 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: claimed is application of inhibitor of cell cycle checkpoint kinase 1 (CHK1), representing some derivatives of N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrole[2,3-b]pyridine-3-yl), or N-(5-bromo-4-(3-(methylamino)piperidin-1-yl)-5-bromo-1H-pyrrole[2,3-b]pyridine-3-yl)nicotinamide, for amplification of DNA-damaging agent, with first dose of said inhibitor being introduced 1 day after DNA-damaging agent, and second dose - two days after DNA-damaging agent.

EFFECT: claimed compounds amplified effect of DNA-damaging agent irinotecan or gemcitabine on tumour cells.

30 cl, 13 dwg, 8 tbl, 12 ex

Similar patents RU2567044C2

Title Year Author Number
COMBINATION OF CHEKPOINT-KINASE 1 INHIBITORS AND WEE 1 KINASE INHIBITORS 2011
  • Dejvis Kertis D.
  • Gros Stefan
RU2627841C2
INTERMEDIATE CHEMICAL COMPOUNDS AND METHODS FOR PRODUCING COMPOUNDS 2013
  • Khan Chun
RU2635359C2
5-(PYRIDINE-2-YLAMINO)-PYRASIN-2-CARBONITRILE COMPOUNDS AND THEIR THERAPEUTIC APPLICATION 2012
  • Kollins Yan
  • Lejnchbari Majkl
  • Mettyus Tomas Piter
  • Rider Dzhon Charlz
RU2641693C2
COMBINATIONS OF INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE AND CHEMIOTHERAPEUTIC AGENTS AND METHODS OF APPLICATION 2008
  • Belvin Marsija
  • Fridman Lori
  • Kheflikh Klaus
  • Sampat Dipak
  • Vidzhapurkar Ulka
  • Vallin Dzheffri
  • Dzhonson Lejza
  • Singkh Mallika
  • Patel' Sonal'
RU2523890C2
SYNERGIC METHODS AND COMPOSITIONS FOR CANCER TREATMENT 2001
  • Li Frehnsis I.
RU2264217C2
QUINAZOLINE COMPOUNDS 2011
  • Chzhan Vehjkhan'
  • Su Vehj-Go
  • Jan Khajbin'
  • Tsuj Jujmin'
  • Zhehn' Junsin'
  • Jan' Sjaotsjan
RU2530887C2
COMBINED COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING BENZOPHENONE-THIAZOLE DERIVATIVES AS VDA AND TOPOISOMERASE INHIBITOR 2017
  • Kim, Soo Jin
  • Kim, Young Sang
  • Kim, Minchae
  • Park, Young-Whan
  • Kim, Jung-Yong
  • Kim, In Chull
RU2724341C1
COMBINED THERAPY WITH (2R,Z)-2-AMINO-2-CYCLOHEXYL-N-(5-(1-METHYL-1H-PIRAZOLE-4-YL)-1-OXO-2,6-DIHYDRO-1H-[1,2]DIAZEPINO[4,5,6-cd]INDOLE-8-YL)ACETAMIDE 2007
  • Ehnderes Kenna Linn
  • Blazina Alessandra
RU2409361C2
PYRROLOPYRIDINES AS KINASE INHIBITORS 2009
  • Le Khjurou Ivan
  • Blehjk Dzhejms F.
  • Ganvordana Indrani U.
  • Mor Peter Dzh.
  • Uolles Ilaj M.
  • Vang Bin
  • Chikarelli Mark
  • Lajon Majkl
RU2517194C2
MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE-3-KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER 2013
  • Belvin Marsiya
  • Fridman Lori
  • Sampat Dipak
  • Vallin Dzheffri
RU2665949C2

RU 2 567 044 C2

Authors

Khamfris Majkl Dzh.

Vinski Shannon L.

Dates

2015-10-27Published

2010-04-09Filed